| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4190352 | Psychiatry | 2006 | 5 Pages |
Abstract
The pharmacological treatment of mood disorders remains focused around the use of monoamine potentiating agents for the management of depression. There are, however, a growing number of agents available for management of bipolar disorder, with both anticonvulsants and atypical antipsychotic drugs showing promise in the management of bipolar depression.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Psychiatry and Mental Health
Authors
Sarah Gartside, Philip Cowen,